Hans Beerlage, Han Teerink, Marian Scheele, Jurgen van der Meer, Mark Jan Arends, Floris van de Bult, Michiel Sunderman, Evert van der Kaa, Sara Schermerhorn, Bauke de Vries, Tjerk de Jonge, Alex Bafi, Olivier Plessis
Clifford Chance, Amsterdam, Clifford Chance, Paris, Clifford Chance, London, Clifford Chance, Luxembourg
Orrick has advised JD.com, Inc. (JD) on its HK$899 million (US$115 million) strategic investment in China Logistics Property Holdings Co., Ltd. (CNLP), representing approximately 9.90% of the enlarged share capital of CNLP following the investment. In connection with this investment, JD has the right to nominate one non-executive director to be appointed to the board of directors of CNLP.
International law firm Pinsent Masons has advised STS Group AG on its admission to the Frankfurt Stock Exchange (Prime Standard) in a deal valuing the business at €144m.
STS Group AG is one of the world's leading suppliers of interior and exterior parts for commercial vehicles. Its components are found in vehicles produced by leading commercial vehicle manufacturers and major international automobile manufacturers (OEMs) as Volvo Trucks, Daimler Trucks, Scania, IVECO, and FCA.
Philadelphia, 12 June 2018 – Hogan Lovells advised OptiNose, Inc., a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat, and allergy specialists, in an approximate $120.2 million public offering led by Jefferies and Piper Jaffray.
DLA Piper advised ADMA Biologics, Inc. (Nasdaq: ADMA) in its underwritten follow-on public offering of common stock valued at approximately US$40 million.
Milbank represented Merrill Lynch International and Goldman Sachs International as placement agents in connection with the private placement of £98,300,000 aggregate principal amount of 8.375% senior secured notes due 2023 issued by Ardonagh Midco 3 plc.
Ardonagh is a leading diversified independent insurance intermediary in the United Kingdom.
The Milbank team was led by Rebecca Marques.
Slaughter and May advised Aquis Exchange PLC (Aquis) on its initial public offering and admission to listing on the AIM market of the London Stock Exchange. Admission and commencement of dealings is expected to take place at 8.00 a.m. on 14 June 2018. Aquis is a pan-European equities exchange operator and technology service provider, which offers trading in approximately 1,200 equities in Europe across 14 countries.
The offer price of 269 pence per ordinary share will give Aquis a market capitalisation on admission of approximately £73 million.
Contacts
On 8th June 2018, King & Wood Mallesons (“KWM”) advised Foxconn Industrial Internet Co., Ltd. (“FII”) on its successful listing on the Shanghai Stock Exchange. As one of the top manufacturing unicorn enterprises, FII issued 1.96 billion shares with an offering price of RMB 13.77 per share, raising more than RMB 27.1 billion. The successful completion marks one of the largest A-share IPOs in the past three years to the date, and ranks as the 11th largest listing of A-share capital markets in China.
King & Wood Mallesons (KWM) advised the sole sponsor and underwriters under the laws of the Hong Kong SAR on the initial public offering (IPO) of Dowway Holdings Limited (Dowway Holdings, Stock Code: 8403) on GEM of The Stock Exchange of Hong Kong by way of share offer.
Cooley advised ASLAN Pharmaceuticals Limited on its $42 million initial public offering of 6,000,000 American Depositary Shares, each representing five ordinary shares. Cooley partners Patrick Loofbourrow, Charlie Kim, Rob Phillips, Sean Clayton and Dave Peinsipp led the team advising Aslan.
Leerink Partners and Piper Jaffray acted as joint book-running managers for the offering. BTIG, H.C. Wainwright & Co. and CLSA acted as co-managers for the offering.